References
- Rudd RA, Paulozzi LJ, Bauer MJ, et al. Increases in heroin overdose deaths - 28 States, 2010 to 2012. MMWR. 2014;63(39):849–854.
- Chen LH, Hedegaard H, Warner M. Drug-poisoning deaths involving opioid analgesics: United States, 1999–2011. NCHS Data Brief. 2014;(166):1–8.
- Coffin PO, Galea S, Ahern J, Leon AC, Vlahov D, Tardiff K. Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990–98. Addiction (Abingdon, England). 2003;98(6):739–747. doi:https://doi.org/10.1046/j.1360-0443.2003.00376.x.
- Ickowicz S, Wood E, Dong H, Nguyen P, Small W, Kerr T, Montaner JSG, Milloy M-J. Association between public injecting and drug-related harm among HIV-positive people who use injection drugs in a Canadian setting: a longitudinal analysis. Drug Alcohol Depend. 2017;180:33–38. doi:https://doi.org/10.1016/j.drugalcdep.2017.07.016.
- Marshall BD, Milloy MJ, Wood E, Montaner JS, Kerr T. Reduction in overdose mortality after the opening of North America’s first medically supervised safer injecting facility: a retrospective population-based study. Lancet (London, England). 2011;377(9775):1429–1437. doi:https://doi.org/10.1016/S0140-6736(10)62353-7.
- Pizzicato LN, Johnson CC, Viner KM. Correlates of experiencing and witnessing non-fatal opioid overdoses among individuals accessing harm reduction services in Philadelphia, Pennsylvania. Subst Abus. 2020;41(3):301–306. doi:https://doi.org/10.1080/08897077.2019.1675115.
- Walley AY, Cheng DM, Coleman SM, Krupitsky E, Raj A, Blokhina E, Bridden C, Chaisson CE, Lira MC, Samet JH, et al. Risk factors for recent nonfatal overdose among HIV-infected Russians who inject drugs. AIDS Care. 2014;26(8):1013–1018. doi:https://doi.org/10.1080/09540121.2013.871218.
- Kinner SA, Milloy MJ, Wood E, Qi J, Zhang R, Kerr T. Incidence and risk factors for non-fatal overdose among a cohort of recently incarcerated illicit drug users. Addict Behav. 2012;37(6):691–696. doi:https://doi.org/10.1016/j.addbeh.2012.01.019.
- Bazazi AR, Zelenev A, Fu JJ, Yee I, Kamarulzaman A, Altice FL. High prevalence of non-fatal overdose among people who inject drugs in Malaysia: correlates of overdose and implications for overdose prevention from a cross-sectional study. Int J Drug Policy. 2015;26(7):675–681. doi:https://doi.org/10.1016/j.drugpo.2014.11.010.
- Heinze G, Schemper M. A solution to the problem of separation in logistic regression. Stat Med. 2002;21(16):2409–2419. doi:https://doi.org/10.1002/sim.1047.
- Darke S, Zador D. Fatal heroin ‘overdose’: a review. Addiction. 1996;91(12):1765–1772. doi:https://doi.org/10.1046/j.1360-0443.1996.911217652.x.
- Gossop M, Griffiths P, Powis B, Williamson S, Strang J. Frequency of non-fatal heroin overdose: survey of heroin users recruited in non-clinical settings. BMJ (Clinical Research ed). 1996;313(7054):402. doi:https://doi.org/10.1136/bmj.313.7054.402.
- Powis B, Strang J, Griffiths P, Taylor C, Williamson S, Fountain J, Gossop M. Self-reported overdose among injecting drug users in London: extent and nature of the problem. Addiction (Abingdon, England). 1999;94(4):471–478. doi:https://doi.org/10.1046/j.1360-0443.1999.9444712.x.
- Brugal MT, Barrio G, De LF, Regidor E, Royuela L, Suelves JM. Factors associated with non-fatal heroin overdose: assessing the effect of frequency and route of heroin administration. Addiction. 2002;97(3):319–327. doi:https://doi.org/10.1046/j.1360-0443.2002.00058.x.
- Darke S, Hall W. Heroin overdose: research and evidence-based intervention. J Urban Health. 2003;80(2):189–200. doi:https://doi.org/10.1093/jurban/jtg022.
- Darke S, Ross J, Hall W. Overdose among heroin users in Sydney, Australia: I. Prevalence and correlates of non-fatal overdose. Addiction. 1996;91(3):405–411.
- Dietze P, Jolley D, Fry C, Bammer G. Transient changes in behaviour lead to heroin overdose: results from a case-crossover study of non-fatal overdose. Addiction. 2005;100(5):636–642. doi:https://doi.org/10.1111/j.1360-0443.2005.01051.x.
- Green TC, Grau LE, Blinnikova KN, et al. Social and structural aspects of the overdose risk environment in St. Petersburg, Russia. Int J Drug Policy. 2009;20(3):270–276.
- Mueller SR, Glanz JM, Nguyen AP, Stowell M, Koester S, Rinehart DJ, Binswanger IA. Restrictive opioid prescribing policies and evolving risk environments: a qualitative study of the perspectives of patients who experienced an accidental opioid overdose. Int J Drug Policy. 2021;92:103077. doi:https://doi.org/10.1016/j.drugpo.2020.103077.
- Strang J, McCambridge J, Best D, Beswick T, Bearn J, Rees S, Gossop M. Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study. BMJ. 2003;326(7396):959–960. doi:https://doi.org/10.1136/bmj.326.7396.959.
- Binswanger IA, Stern MF, Deyo RA, Heagerty PJ, Cheadle A, Elmore JG, Koepsell TD. Release from prison-a high risk of death for former inmates. N Engl J Med. 2007;356(2):157–165. doi:https://doi.org/10.1056/NEJMsa064115.
- Bird SM, Hutchinson SJ. Male drugs-related deaths in the fortnight after release from prison: Scotland, 1996–99. Addiction. 2003;98(2):185–190. doi:https://doi.org/10.1046/j.1360-0443.2003.00264.x.
- Bohnert ASB, Nandi A, Tracy M, Cerdá M, Tardiff KJ, Vlahov D, Galea S. Policing and risk of overdose mortality in urban neighborhoods. Drug Alcohol Depend. 2011;113(1):62–68. doi:https://doi.org/10.1016/j.drugalcdep.2010.07.008.
- Dovey K, Fitzgerald J, Choi Y. Safety becomes danger: dilemmas of drug-use in public space. Health Place. 2001;7(4):319–331. doi:https://doi.org/10.1016/s1353-8292(01)00024-7.
- Milloy M-JS, Kerr T, Mathias R, Zhang R, Montaner JS, Tyndall M, Wood E. Non-fatal overdose among a cohort of active injection drug users recruited from a supervised injection facility. Am J Drug Alcohol Abuse. 2008;34(4):499–509. doi:https://doi.org/10.1080/00952990802122457.
- Rhodes T. The ‘risk environment’: a framework for understanding and reducing drug-related harm. Int J Drug Policy. 2002;13(2):85–94. doi:https://doi.org/10.1016/S0955-3959(02)00007-5.
- Broadhead RS, Kerr TH, Grund J-PC, Altice FL. Safer injection facilities in North America: their place in public policy and health initiatives. J Drug Issues. 2002;32(1):329–355. doi:https://doi.org/10.1177/002204260203200113.
- DeBeck K, Small W, Wood E, Li K, Montaner J, Kerr T. Public injecting among a cohort of injecting drug users in Vancouver, Canada. J Epidemiol Community Health. 2009;63(1):81–86. doi:https://doi.org/10.1136/jech.2007.069013.
- Holtzman D, Barry V, Ouellet LJ, Des Jarlais DC, Vlahov D, Golub ET, Hudson SM, Garfein RS. The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994–2004. Prev Med. 2009;49(1):68–73. doi:https://doi.org/10.1016/j.ypmed.2009.04.014.
- Navarro C, Leonard L. Prevalence and factors related to public injecting in Ottawa, Canada: implications for the development of a trial safer injecting facility. Int J Drug Policy. 2004;15(4):275–284. doi:https://doi.org/10.1016/j.drugpo.2004.03.003.
- Small W, Rhodes T, Wood E, Kerr T. Public injection settings in Vancouver: physical environment, social context and risk. Int J Drug Policy. 2007;18(1):27–36. doi:https://doi.org/10.1016/j.drugpo.2006.11.019.
- Tempalski B, McQuie H. Drugscapes and the role of place and space in injection drug use-related HIV risk environments. Int J Drug Policy. 2009;20(1):4–13. doi:https://doi.org/10.1016/j.drugpo.2008.02.002.
- Colledge S, Peacock A, Leung J, Larney S, Grebely J, Hickman M, Cunningham E, Trickey A, Stone J, Vickerman P, et al. The prevalence of non-fatal overdose among people who inject drugs: a multi-stage systematic review and meta-analysis. Int J Drug Policy. 2019;73:172–184. doi:https://doi.org/10.1016/j.drugpo.2019.07.030.
- Bayani A, Ghiasvand H, Rezaei O, Fattah Moghaddam L, Noroozi A, Ahounbar E, Higgs P, Armoon B. Factors associated with HIV testing among people who inject drugs: a meta-analysis. J Addict Dis. 2020;38(3):361–374. doi:https://doi.org/10.1080/10550887.2020.1771235.
- Rezaei O, Ghiasvand H, Higgs P, Noroozi A, Noroozi M, Rezaei F, Armoon B, Bayani A. Factors associated with injecting-related risk behaviors among people who inject drugs: a systematic review and meta-analysis study. J Addict Dis. 2020;38(4):420–437. doi:https://doi.org/10.1080/10550887.2020.1781346.
- Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–605. doi:https://doi.org/10.1007/s10654-010-9491-z.
- Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159–174. doi:https://doi.org/10.2307/2529310.
- Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–1101. doi:https://doi.org/10.2307/2533446.
- Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634. doi:https://doi.org/10.1136/bmj.315.7109.629.
- Bergenstrom A, Quan VM, Van Nam L, McClausland K, Thuoc NP, Celentano D, Go V. A cross-sectional study on prevalence of non-fatal drug overdose and associated risk characteristics among out-of-treatment injecting drug users in North Vietnam. Subst Use Misuse. 2008;43(1):73–84. doi:https://doi.org/10.1080/10826080701205109.
- Blackburn NA, Lancaster KE, Ha TV, Latkin CA, Miller WC, Frangakis C, Chu VA, Sripaipan T, Quan VM, Minh NL, et al. Characteristics of persons who inject drugs and who witness opioid overdoses in Vietnam: a cross-sectional analysis to inform future overdose prevention programs. Harm Reduct J. 2017;14(1):1–9. doi:https://doi.org/10.1186/s12954-017-0188-4.
- Britton PC, Wines JD, Jr, Conner KR. Non-fatal overdose in the 12 months following treatment for substance use disorders. Drug Alcohol Depend. 2010;107(1):51–55. doi:https://doi.org/10.1016/j.drugalcdep.2009.09.005.
- Burke LG, Zhou X, Boyle KL, Orav EJ, Bernson D, Hood M-E, Land T, Bharel M, Frakt AB. Trends in opioid use disorder and overdose among opioid-naive individuals receiving an opioid prescription in Massachusetts from 2011 to 2014. Addiction. 2020;115(3):493–504. doi:https://doi.org/10.1111/add.14867.
- Chahua M, Sordo L, Barrio G, Domingo-Salvany A, Brugal MT, Molist G, de la Fuente L, Bravo MJ, ITINERE Project Group. Non-fatal opioid overdose and major depression among street-recruited young heroin users. Eur Addict Res. 2014;20(1):1–7. doi:https://doi.org/10.1159/000346787.
- Cheng T, Small W, Nosova E, Hogg R, Hayashi K, Kerr T, DeBeck K. Overdose Risk and Acquiring Opioids for Nonmedical Use Exclusively from Physicians in Vancouver, Canada. Subst Use Misuse. 2020;55(12):1912–1918. doi:https://doi.org/10.1080/10826084.2020.1781176.
- Cochran G, Gordon AJ, Gellad WF, et al. Medicaid prior authorization and opioid medication abuse and overdose. Am J Manag Care. 2017;23(5):e164.
- Coffin PO, Tracy M, Bucciarelli A, Ompad D, Vlahov D, Galea S. Identifying injection drug users at risk of nonfatal overdose. Acad Emerg Med. 2007;14(7):616–623. doi:https://doi.org/10.1197/j.aem.2007.04.005.
- Darke S, Ross J. Overdose risk perceptions and behaviours among heroin users in Sydney, Australia. Eur Addict Res. 1997;3(2):87–92. doi:https://doi.org/10.1159/000259156.
- Darke S, Williamson A, Ross J, Teesson M. Non-fatal heroin overdose, treatment exposure and client characteristics: findings from the Australian treatment outcome study (ATOS). Drug Alcohol Rev. 2005;24(5):425–432. doi:https://doi.org/10.1080/09595230500286005.
- Dilokthornsakul P, Moore G, Campbell JD, Lodge R, Traugott C, Zerzan J, Allen R, Page RL. Risk factors of prescription opioid overdose among Colorado Medicaid beneficiaries. J Pain. 2016;17(4):436–443. doi:https://doi.org/10.1016/j.jpain.2015.12.006.
- Escudero DJ, Marshall BDL, Kerr T, Hayashi K, Feng C, Guillemi SA, Hogg RS, Montaner J, Wood E, Milloy M-J, et al. No association between HIV status and risk of non-fatal overdose among people who inject drugs in Vancouver, Canada. Addict Behav. 2016;60:8–12. doi:https://doi.org/10.1016/j.addbeh.2016.03.029.
- Fairbairn N, Wood E, Stoltz J-a, Li K, Montaner J, Kerr T. Crystal methamphetamine use associated with non-fatal overdose among a cohort of injection drug users in Vancouver. Public Health. 2008;122(1):70–78. doi:https://doi.org/10.1016/j.puhe.2007.02.016.
- Fairgrieve C, Nosova E, Milloy M-J, Fairbairn N, DeBeck K, Ahamad K, Wood E, Kerr T, Hayashi K. Temporal changes in non-fatal opioid overdose patterns among people who use drugs in a Canadian setting. Subst Abus. 2020;41(3):323–330. doi:https://doi.org/10.1080/08897077.2019.1677280.
- Fischer B, Brissette S, Brochu S, et al. Determinants of overdose incidents among illicit opioid users in 5 Canadian cities. CMAJ. 2004;171(3):235–239. doi:https://doi.org/10.1503/cmaj.1031416.
- Galea S, Nandi A, Coffin PO, Tracy M, Markham Piper T, Ompad D, Vlahov D. Heroin and cocaine dependence and the risk of accidental non-fatal drug overdose. J Addict Dis. 2006;25(3):79–87. doi:https://doi.org/10.1300/J069v25n03_10.
- Groenewald CB, Zhou C, Palermo TM, Van Cleve WC. Associations between opioid prescribing patterns and overdose among privately insured adolescents. Pediatrics. 2019;144(5):e20184070. doi:https://doi.org/10.1542/peds.2018-4070.
- Hakansson A, Schlyter F, Berglund M. Factors associated with history of non-fatal overdose among opioid users in the Swedish criminal justice system. Drug Alcohol Depend. 2008;94(1–3):48–55. doi:https://doi.org/10.1016/j.drugalcdep.2007.10.014.
- Hunter K, Park JN, Allen ST, Chaulk P, Frost T, Weir BW, Sherman SG. Safe and unsafe spaces: non-fatal overdose, arrest, and receptive syringe sharing among people who inject drugs in public and semi-public spaces in Baltimore City. Int J Drug Policy. 2018;57:25–31. doi:https://doi.org/10.1016/j.drugpo.2018.03.026.
- Kerr T, Fairbairn N, Tyndall M, Marsh D, Li K, Montaner J, Wood E. Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug Alcohol Depend. 2007;87(1):39–45. doi:https://doi.org/10.1016/j.drugalcdep.2006.07.009.
- Kilaru AS, Xiong A, Lowenstein M, Meisel ZF, Perrone J, Khatri U, Mitra N, Delgado MK. Incidence of treatment for opioid use disorder following nonfatal overdose in commercially insured patients. JAMA Netw Open. 2020;3(5):e205852. doi:https://doi.org/10.1001/jamanetworkopen.2020.5852.
- Lagu T, Anderson BJ, Stein M. Overdoses among friends: drug users are willing to administer naloxone to others. J Subst Abuse Treat. 2006;30(2):129–133. doi:https://doi.org/10.1016/j.jsat.2005.05.010.
- Lake S, Hayashi K, Buxton J, Milloy M-J, Dong H, Wood E, Montaner J, Kerr T. The effect of prescription opioid injection on the risk of non-fatal overdose among people who inject drugs. Drug Alcohol Depend. 2015;156:297–303. doi:https://doi.org/10.1016/j.drugalcdep.2015.09.026.
- Mateu-Gelabert P, Guarino H, Zibbell JE, Teubl J, Fong C, Goodbody E, Edlin B, Salvati C, Friedman SR. Prescription opioid injection among young people who inject drugs in New York City: a mixed-methods description and associations with hepatitis C virus infection and overdose. Harm Reduct J. 2020;17(1):1–11. doi:https://doi.org/10.1186/s12954-020-00367-2.
- Mcgregor C, Darke S, Ali R, Christie P. Experience of non-fatal overdose among heroin users in Adelaide, Australia: circumstances and risk perceptions. Addiction. 1998;93(5):701–711. doi:https://doi.org/10.1046/j.1360-0443.1998.9357016.x.
- Milloy M-J, Fairbairn N, Hayashi K, Suwannawong P, Kaplan K, Wood E, Kerr T. Overdose experiences among injection drug users in Bangkok, Thailand. Harm Reduct J. 2010;7(1):7–9. doi:https://doi.org/10.1186/1477-7517-7-9.
- Nam YH, Bilker WB, DeMayo FJ, Neuman MD, Hennessy S. Incidence rates of and risk factors for opioid overdose in new users of prescription opioids among US Medicaid enrollees: a cohort study. Pharmacoepidemiol Drug Saf. 2020;29(8):931–938. doi:https://doi.org/10.1002/pds.5067.
- Noroozi M, Higgs P, Bayani A, Armoon B, Astaneh AN, Moghaddam LF, Askari M. Non-fatal overdose among people who inject drugs in Tehran, Iran. Subst Abuse Treat Prev Policy. 2020;15(1):1–7. doi:https://doi.org/10.1186/s13011-020-00323-0.
- O’Halloran C, Cullen K, Njoroge J, Jessop L, Smith J, Hope V, Ncube F. The extent of and factors associated with self-reported overdose and self-reported receipt of naloxone among people who inject drugs (PWID) in England, Wales and Northern Ireland. Int J Drug Policy. 2017;46:34–40. doi:https://doi.org/10.1016/j.drugpo.2017.05.017.
- Ochoa KC, Davidson PJ, Evans JL, Hahn JA, Page-Shafer K, Moss AR. Heroin overdose among young injection drug users in San Francisco. Drug Alcohol Depend. 2005;80(3):297–302. doi:https://doi.org/10.1016/j.drugalcdep.2005.04.012.
- Park JN, Weir BW, Allen ST, Chaulk P, Sherman SG. Fentanyl-contaminated drugs and non-fatal overdose among people who inject drugs in Baltimore, MD. Harm Reduct J. 2018;15(1):1–8. doi:https://doi.org/10.1186/s12954-018-0240-z.
- Rafful C, Orozco R, Rangel G, Davidson P, Werb D, Beletsky L, Strathdee SA. Increased non-fatal overdose risk associated with involuntary drug treatment in a longitudinal study with people who inject drugs. Addiction. 2018;113(6):1056–1063. doi:https://doi.org/10.1111/add.14159.
- Riley ED, Evans JL, Hahn JA, Briceno A, Davidson PJ, Lum PJ, Page K. A longitudinal study of multiple drug use and overdose among young people who inject drugs. Am J Public Health. 2016;106(5):915–917. doi:https://doi.org/10.2105/AJPH.2016.303084.
- Rowe C, Santos G-M, Behar E, Coffin PO. Correlates of overdose risk perception among illicit opioid users. Drug Alcohol Depend. 2016;159:234–239. doi:https://doi.org/10.1016/j.drugalcdep.2015.12.018.
- Saleem HT, Likindikoki S, Nonyane BAS, Haruna Nkya I, Zhang L, Mbwambo J, Latkin C. Correlates of non-fatal, opioid overdose among women who use opioids in Dar es Salaam, Tanzania. Drug Alcohol Depend. 2021;218:108419. doi:https://doi.org/10.1016/j.drugalcdep.2020.108419.
- Schiavon S, Hodgin K, Sellers A, Word M, Galbraith JW, Dantzler J, Cropsey KL. Medical, psychosocial, and treatment predictors of opioid overdose among high risk opioid users. Addict Behav. 2018;86:51–55. doi:https://doi.org/10.1016/j.addbeh.2018.05.029.
- Seal KH, Kral AH, Gee L, Moore LD, Bluthenthal RN, Lorvick J, Edlin BR. Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998–1999. Am J Public Health. 2001;91(11):1842–1846. doi:https://doi.org/10.2105/ajph.91.11.1842.
- Sherman SG, Cheng Y, Kral AH. Prevalence and correlates of opiate overdose among young injection drug users in a large US city. Drug Alcohol Depend. 2007;88(2–3):182–187. doi:https://doi.org/10.1016/j.drugalcdep.2006.10.006.
- Smolina K, Crabtree A, Chong M, et al. Prescription-related risk factors for opioid-related overdoses in the era of fentanyl contamination of illicit drug supply: a retrospective case-control study. Substance Abuse. 2020;1–7 doi:https://doi.org/10.1080/08897077.2020.1748162.
- Stewart D, Gossop M, Marsden J. Reductions in non-fatal overdose after drug misuse treatment: results from the National Treatment Outcome Research Study (NTORS). J Subst Abuse Treat. 2002;22(1):1–9. doi:https://doi.org/10.1016/S0740-5472(01)00206-9.
- Uusküla A, Raag M, Vorobjov S, Rüütel K, Lyubimova A, Levina OS, Heimer R. Non-fatal overdoses and related risk factors among people who inject drugs in St. Petersburg, Russia and Kohtla-Järve, Estonia. BMC Public Health. 2015;15(1):1–9. doi:https://doi.org/10.1186/s12889-015-2604-6.
- Winter RJ, Stoové M, Degenhardt L, Hellard ME, Spelman T, Jenkinson R, McCarthy DR, Kinner SA. Incidence and predictors of non-fatal drug overdose after release from prison among people who inject drugs in Queensland, Australia. Drug Alcohol Depend. 2015;153:43–49. doi:https://doi.org/10.1016/j.drugalcdep.2015.06.011.
- Yin L, Qin G, Ruan Y, Qian H-Z, Hao C, Xie L, Chen K, Zhang Y, Xia Y, Wu J, et al. Nonfatal overdose among heroin users in southwestern China. Am J Drug Alcohol Abuse. 2007;33(4):505–516. doi:https://doi.org/10.1080/00952990701407223.
- Yule AM, Carrellas NW, DiSalvo M, Lyons RM, McKowen JW, Nargiso JE, Bergman BG, Kelly JF, Wilens TE. Risk factors for overdose in young people who received substance use disorder treatment. Am J Addict. 2019;28(5):382–389. doi:https://doi.org/10.1111/ajad.12938.
- Yule AM, Carrellas NW, Fitzgerald M, McKowen JW, Nargiso JE, Bergman BG, Kelly JF, Wilens TE. Risk factors for overdose in treatment-seeking youth with substance use disorders. J Clin Psychiatry. 2018;79(3):17m11678. doi:https://doi.org/10.4088/JCP.17m11678.
- Zhou Y, Luo W, Cao X, Zhang B, Wu Z. Overdose of heroin and influencing factors in intravenous drug users in parts of Yunnan. Zhonghua Liu Xing Bing Xue Za Zhi. 2016;37(5):648–652. doi:https://doi.org/10.3760/cma.j.issn.0254-6450.2016.05.012.
- Betts KS, McIlwraith F, Dietze P, Whittaker E, Burns L, Cogger S, Alati R. Can differences in the type, nature or amount of polysubstance use explain the increased risk of non-fatal overdose among psychologically distressed people who inject drugs?Drug Alcohol Depend. 2015;154:76–84. doi:https://doi.org/10.1016/j.drugalcdep.2015.06.020.
- Kaye S, Darke S. Non-fatal cocaine overdose among injecting and non-injecting cocaine users in Sydney, Australia. Addiction. 2004;99(10):1315–1322. doi:https://doi.org/10.1111/j.1360-0443.2004.00875.x.
- Kerr T, Wood E, Palepu A, Wilson D, Schechter MT, Tyndall MW. Responding to an explosive HIV epidemic driven by frequent cocaine injection: is there a role for safe injecting facilities?J Drug Issues. 2003;33(3):579–608. doi:https://doi.org/10.1177/002204260303300303.
- Park TW, Larochelle MR, Saitz R, Wang N, Bernson D, Walley AY. Associations between prescribed benzodiazepines, overdose death and buprenorphine discontinuation among people receiving buprenorphine. Addiction. 2020;115(5):924–932. doi:https://doi.org/10.1111/add.14886.
- Bretteville-Jensen AL, Lillehagen M, Gjersing L, Andreas JB. Illicit use of opioid substitution drugs: prevalence, user characteristics, and the association with non-fatal overdoses. Drug Alcohol Depend. 2015;147:89–96. doi:https://doi.org/10.1016/j.drugalcdep.2014.12.002.
- Bazazi AR, Yokell M, Fu JJ, Rich JD, Zaller ND. Illicit use of buprenorphine/naloxone among injecting and noninjecting opioid users. J Addict Med. 2011;5(3):175–180. doi:https://doi.org/10.1097/ADM.0b013e3182034e31.
- Genberg BL, Gillespie M, Schuster CR, Johanson C-E, Astemborski J, Kirk GD, Vlahov D, Mehta SH. Prevalence and correlates of street-obtained buprenorphine use among current and former injectors in Baltimore, Maryland. Addict Behav. 2013;38(12):2868–2873. doi:https://doi.org/10.1016/j.addbeh.2013.08.008.
- Gwin Mitchell S, Kelly SM, Brown BS, Schacht Reisinger H, Peterson JA, Ruhf A, Agar MH, O’Grady KE, Schwartz RP. Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland. Am J Addict. 2009;18(5):346–355. doi:https://doi.org/10.3109/10550490903077820.
- Peckham AM, Young EH. Opportunities to offer harm reduction to people who inject drugs during infectious disease encounters: narrative review. Paper presented at Open Forum Infectious Diseases 2020. doi:https://doi.org/10.1093/ofid/ofaa503.
- Fox AD, Chamberlain A, Sohler NL, Frost T, Cunningham CO. Illicit buprenorphine use, interest in and access to buprenorphine treatment among syringe exchange participants. J Subst Abuse Treat. 2015;48(1):112–116. doi:https://doi.org/10.1016/j.jsat.2014.07.015.
- Warner-Smith M, Darke S, Lynskey M, Hall W. Heroin overdose: causes and consequences. Addiction (Abingdon, England). 2001;96(8):1113–1125. doi:https://doi.org/10.1046/j.1360-0443.2001.96811135.x.
- Darke S, Williamson A, Ross J, Mills KL, Havard A, Teesson M. Patterns of nonfatal heroin overdose over a 3-year period: findings from the Australian treatment outcome study. J Urban Health. 2007;84(2):283–291. doi:https://doi.org/10.1007/s11524-006-9156-0.
- Jolley CJ, Bell J, Rafferty GF, Moxham J, Strang J. Understanding heroin overdose: a study of the acute respiratory depressant effects of injected pharmaceutical heroin. PLoS One. 2015;10(10):e0140995. doi:https://doi.org/10.1371/journal.pone.0140995.
- Yazdanian M, Armoon B, Noroozi A, Mohammadi R, Bayat A-H, Ahounbar E, Higgs P, Nasab HS, Bayani A, Hemmat M, et al. Dental caries and periodontal disease among people who use drugs: a systematic review and meta-analysis. BMC Oral Health. 2020;20(1):44. doi:https://doi.org/10.1186/s12903-020-1010-3.
- Karimi SE, Bayani A, Higgs P, Bayat A-H, Hemmat M, Ahounbar E, Armoon B, Fakhri Y. Prevalence and high risk behaviours associated with HCV testing among people who inject drugs: a systematic review and Meta-analysis. Subst Abuse Treat Prev Policy. 2020;15(1):64. doi:https://doi.org/10.1186/s13011-020-00306-1.
- Bayat A-H, Mohammadi R, Moradi-Joo M, Bayani A, Ahounbar E, Higgs P, Hemmat M, Haghgoo A, Armoon B. HIV and drug related stigma and risk-taking behaviors among people who inject drugs: a systematic review and meta-analysis. J Addict Dis. 2020;38(1):71–83. doi:https://doi.org/10.1080/10550887.2020.1718264.